Efficient mucosal antibody response to SARS-CoV-2 vaccination is induced in previously infected individuals
Kaori Sano(Icahn School of Medicine at Mount Sinai), Florian Krammer(Semmelweis University), Daniel Floda(Icahn School of Medicine at Mount Sinai), Charles Gleason(Icahn School of Medicine at Mount Sinai), Komal Srivastava(Icahn School of Medicine at Mount Sinai), Gagandeep Singh(Icahn School of Medicine at Mount Sinai), Juan Manuel Carreño(Icahn School of Medicine at Mount Sinai), Viviana Simon(Icahn School of Medicine at Mount Sinai), Disha Bhavsar(Icahn School of Medicine at Mount Sinai)
Cited by 23
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses
|Immunity|2021|713
Advances in the development of influenza virus vaccines
|Nature Reviews Drug Discovery|2015|597